Therapeutic effect of photodynamic therapy using hematoporphyrin monomethyl ether (HMME) on human cholangiocarcinoma cell line QBC939

Neoplasma

Volumn 57, Issue 1, 2010, Pages 79-85

  Wang, J B ^a   Liu, L X ^a   Pan, S H ^a   Wang, C Y ^a   Fu, Q F ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cholangiocarcinoma; Hematoporphyrin monomethyl ether; Photodynamic therapy

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYTOCHROME C; DNA NUCLEOTIDYLEXOTRANSFERASE; HEMATOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN MONOMETHYL ETHER; LIPOCORTIN 5; PHOTOSENSITIZING AGENT; PROCASPASE 3; PROPIDIUM IODIDE; UNCLASSIFIED DRUG; CASPASE 3; HEMATOPORPHYRIN;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; BIOASSAY; CANCER CELL CULTURE; CANCER CELL LINE QBC939; CANCER PATIENT; CELL DEATH; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DIODE LASER; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NICK END LABELING; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; RADIATION ENERGY; THERAPY EFFECT; WESTERN BLOTTING; BILE DUCT TUMOR; DRUG EFFECT; INTRAHEPATIC BILE DUCT; METABOLISM; PATHOLOGY; PHOTOCHEMOTHERAPY; TUMOR CELL LINE;

APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CASPASE 3; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; CYTOCHROMES C; HEMATOPORPHYRINS; HUMANS; PHOTOCHEMOTHERAPY;

EID: 77951298635     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_01_079     Document Type: Article

References (22)

1. IGARASHI A, KONNO H, TANAKA T, NAKAMURA S, SADZUKA Y, et al. Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer. Toxicol Lett 2003; 145: 133-141. doi:10.1016/S0378-4274(03)00241-8
2. LIPSON RL, BALDES EJ, OLSEN AM. The use of a derivative of hematoporphyrin in tumor detection. J Natl Cancer Inst 1961; 26: 1-11.
3. SHARMAN WM, ALLEN CM, VAN LIER JE. Photodynamic therapeutics: basic principles and clinical applications. Drug Discov Today. 1999; 4: 507-517. doi:10.1016/S1359-6446(99)01412-9
4. SVAASAND LO. Optical dosimetry for direct and interstitial photoradiation therapy of malignant tumors. Prog Clin Biol Res. 1984; 170: 91-114.
5. DOUGHERTY TJ. An update on photodynamic therapy applications. J Clin Laser Med Surg. 2002; 20: 3-7. doi:10.1089/104454702753474931
6. CARRUTH JA. Clinical applications of photodynamic therapy. Int J Clin Pract. 1998; 52: 39-42.
7. ZHENG H. Photodynamic therapy in China: over 25 years of unique clinical experience. Part one-history and domestic photosensitizers. Photodiag Photodynamic Ther. 2006; 3: 3-10. doi:10.1016/S1572-1000(06)00009-3
8. XU DY. Research and development of photodynamic therapy photosensitizers in China. Photodiag Photodynamic Ther. 2007; 4: 13-25. doi:10.1016/j.pdpdt.2006.09.003
9. AYARU L, BOWN SG, PEREIRA SP. Photodynamic therapy for pancreatic and biliary tract carcinoma. Int J Gastrointest Cancer. 2005; 35: 1-13. doi:10.1385/IJGC:35:1:001
10. LAZARIDIS KN, GORES GJ. Cholangiocarcinoma. Gastroenterology. 2005; 128: 1655-1667. doi:10.1053/j.gastro.2005.03.040
11. DE GROEN PC, GORES GJ, LARUSSO NF, GUNDERSON LL, NAGORNEY DM. Biliary tract cancers. N Engl J Med. 1999; 341: 1368-1378. doi:10.1056/NEJM199910283411807
12. LEONARD GD, O'REILLY EM. Biliary tract cancers: current concepts and controversies. Expert Opin Pharmacother. 2005; 6: 211-223. doi:10.1517/14656566.6.2.211
13. WANG JB, LIU LX. Use of photodynamic therapy in malignant lesions of stomach, bile duct, pancreas, colon and rectum. Hepatogastroenterology. 2007; 54: 718-724.
14. ORTNER MA, DORTA G. Technology insight: Photodynamic therapy for cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006; 3: 459-467. doi:10.1038/ncpgasthep0543
15. WONG KEE SONG LM, WANG KK, ZINSMEISTER AR. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangio-carcinoma model. Cancer. 1998; 82: 421-427. doi:10.1002/1097-0142(19980115)82:2<421::AIDCNCR25> 3.0.CO;2-O
16. RUMALLA A, BARON TH, WANG KK, GORES GJ, STADHEIM LM, et al. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc. 2001; 53: 500-504. doi:10.1067/mge.2001.113386
17. ORTNER MA. Photodynamic therapy of cholangiocarcinoma cancer. Gastrointest Endosc Clin N Am. 2000; 10: 481-486.
18. ORTNER ME, CACA K, BERR F, LIEBETRUTH J, MANSMANN U, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003; 125: 1355-1363. doi:10.1016/ j.gastro.2003.07.015
19. CASAS A, FUKUDA H, DI VENOSA G, BATLLE A. Photosensitization and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer. 2001; 85: 279-284. doi:10.1054/bjoc.2001.1875
20. WOODBURN KW, FAN Q, MILES DR, KESSEL D, LUO Y, et al. Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Photochem Photobiol. 1997; 65: 410-415. doi:10.1111/j.1751-1097.1997.tb08579.x
21. WYLD L, REED MW, BROWN NJ. Differential cell death response to photodynamic therapy is dependent on dose and cell type, Br. J. Cancer. 2001; 84: 1384-1386. doi:10.1054/ bjoc.2001.1795
22. ORTNER M. Photodynamic therapy for cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2001; 8: 137-139. doi:10.1007/ s005340170036